Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home Investor Relations Financial Information

Financial Information

Annual Financial Reports

 

Annual Report 2009 Annual report 2009 (3MB)

Annual report 2009 (19MB)
   
Annual report 2008 (3MB)
Annual report 2007 (3MB)

Half-Year Financial Reports

 

Interim Management Reports

 

 

 

Latest News


27/07/2010

ABLYNX ANNOUNCES CHANGE IN MANAGEMENT

23/07/2010

ABLYNX ANNOUNCES WARRANT EXERCISE

12/07/2010

NOVARTIS OBTAINS LICENSES TO DEVELOP AND COMMERCIALISE TWO NOVEL NANOBODIES®


Email alerts

If you would like to receive updates on the company news, please
click here